Curis, Inc. to Present at Piper Jaffray 21st Annual Healthcare Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Curis, Inc. (NASDAQ: CRIS), a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that the Company will be presenting at the Piper Jaffray 21st Annual Healthcare Conference at 11:00 a.m. EST on December 2, 2009, in New York City.

Back to news